A STUDY OF BLOOD GROUP IN COVID-19 PATIENTS IN TERTIARY CARE HOSPITAL OF AHMEDABAD CITY, GUJARAT, INDIA - AN INSTITUTIONAL STUDY
Introduction: The associations between ABO system of blood and COVID-19 infection in various studies provide reason to think true associations may be in reality between blood type and incidence of COVID-19 and death due to COVID-19. Objectives: To estimate frequency of COVID-19 illness in different ABO blood systems and also to find linkage between the ABO system of blood and degree of COVID-19 illness. Methods: A prospective cohort study was conducted on all COVID-19 patients (Patients were grouped A positive and A negative blood groups into 1st group and other blood types such as B, AB, and O, irrespective of their Rh status, into 2nd group) admitted at Tertiary Care Hospital of Ahmedabad City, Gujarat, India during the four months of study duration. Results: COVID-19 infection was found in 380 (63.3%) male. Mean age was 56.46 ±15.35 years in which 26.8% patients were in age group of 60 to 70 years. Among total 600 patients, 35% of patients were having B positive type of blood followed by O positive type of blood (25%). There were 25% of patients having overall co-morbidity like diabetes. And 8% of B positive patient having co-morbidity and amongst the, 1.2% patients were admitted to Intensive Care Unit. Case fatality rate was 7.5%. Among B positive blood group patients, 37.8% deaths occurred. Conclusion: Patients having blood group O may have lower chances of ICU admission as compared to other blood groups.
Agrawal, A., Tiwari, A.K., Mehta, N., Bhattacharya, P., Wankhede, R., Tulsiani, S. and Kamath, S., 2014. ABO and Rh (D) group distribution and gene frequency; the first multicentric study in India. Asian Journal of Transfusion Science, [online] 8(2), pp.121–125. https://doi.org/10.4103/0973-6247.137452.
Ali Almadhi, M., Abdulrahman, A., Alawadhi, A., Rabaan, A.A., Atkin, S., AlQahtani, M., bin Khalifa Cardiac Centre, M., Hopkins Aramco Healthcare, J. and Arabia, S., 123AD. The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes Methods OPEN 1 National Taskforce for Combating the Coronavirus (COVID-19). Scientific Reports |, [online] 11, p.5745. https://doi.org/10.1038/s41598-021-84810-9.
Anderson, J.L., May, H.T., Knight, S., Bair, T.L., Muhlestein, J.B., Knowlton, K.U. and Horne, B.D., 2021. Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population. JAMA Network Open, [online] 4(4), pp.e217429–e217429. https://doi.org/10.1001/JAMANETWORKOPEN.2021.7429.
Anon 2022. Sample Size Calculator by Raosoft, Inc. [online] Available at: <http://www.raosoft.com/samplesize.html> [Accessed 31 Jan. 2022].
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L. and Wang, M., 2020. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA, [online] 323(14), pp.1406–1407. https://doi.org/10.1001/JAMA.2020.2565.
Barnkob, M.B., Pottegård, A., Støvring, H., Haunstrup, T.M., Homburg, K., Larsen, R., Hansen, M.B., Titlestad, K., Aagaard, B., Møller, B.K. and Barington, T., 2020. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O.
Blood Advances, [online] 4(20), pp.4990–4993. https://doi.org/10.1182/BLOODADVANCES.2020002657.
CA, L., C, D., L, B., CYM, P., R, P., MF, C., M, E. and A, D., 2020. Blood type and outcomes in patients with COVID-19. Annals of hematology, [online] 99(9), pp.2113–2118. https://doi.org/10.1007/S00277-020-04169-1.
Hoiland, R.L., Fergusson, N.A., Mitra, A.R., Griesdale, D.E.G., Devine, D. v., Stukas, S., Cooper, J., Thiara, S., Foster, D., Chen, L.Y.C., Lee, A.Y.Y., Conway, E.M., Wellington, C.L. and Sekhon, M.S., 2020. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Advances, [online] 4(20), pp.4981–4989. https://doi.org/10.1182/BLOODADVANCES.2020002623.
J, L. and R, H., 2017. RNA-virus proteases counteracting host innate immunity. FEBS letters, [online] 591(20), pp.3190–3210. https://doi.org/10.1002/1873-3468.12827.
Karim, S., Hoque, M.M., Hoque, E., Begum, H.A., Rahman, S.M., Shah, T.A. and Hossain, S.Z., 2015. The Distribution of Abo and Rhesus Blood Groups Among Blood Donor Attending Transfusion Medicine Department of Dhaka Medical College Hospital in 2014. Journal of Dhaka Medical College, [online] 24(1), pp.53–56. https://doi.org/10.3329/JDMC.V24I1.29564.
Lai, C.-C., Liu, Y.H., Wang, C.-Y., Wang, Y.-H., Hsueh, S.-C., Yen, M.-Y., Ko, W.-C. and Hsueh, P.-R., 2020. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. Journal of Microbiology, Immunology, and Infection, [online] 53(3), p.404. https://doi.org/10.1016/J.JMII.2020.02.012.
Latz, C.A., DeCarlo, C., Boitano, L., Png, C.Y.M., Patell, R., Conrad, M.F., Eagleton, M. and Dua, A., 2020. Blood type and outcomes in patients with COVID-19. Annals of Hematology, [online] 99(9), pp.2113–2118. https://doi.org/10.1007/s00277-020-04169-1.
Lei, J. and Hilgenfeld, R., 2017. RNA‐virus proteases counteracting host innate immunity. Febs Letters, [online] 591(20), p.3190. https://doi.org/10.1002/1873-3468.12827.
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., Chen, J., Meng, Y., Wang, J., Lin, Y., Yuan, J., Xie, Z., Ma, J., Liu, W.J., Wang, D., Xu, W., Holmes, E.C., Gao, G.F., Wu, G., Chen, W., Shi, W. and Tan, W., 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, [online] 395(10224), pp.565–574. https://doi.org/10.1016/S0140-6736(20)30251-8.
Mahmud, R., Rassel, M.A., Monayem, F.B., Sayeed, S.K.J.B., Islam, M.S., Islam, M.M., Yusuf, M.A., Rahman, S., Islam, K.M.N., Mahmud, I., Hossain, M.Z., Chowdhury, A.H., Kabir, A.K.M.H., Ahmed, K.G.U. and Rahman, Md.M., 2021a. Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh. PLOS ONE, [online] 16(4), p.e0249252. https://doi.org/10.1371/JOURNAL.PONE.0249252.
Mahmud, R., Rassel, M.A., Monayem, F.B., Sayeed, S.K.J.B., Islam, M.S., Islam, M.M., Yusuf, M.A., Rahman, S., Islam, K.M.N., Mahmud, I., Hossain, M.Z., Chowdhury, A.H., Kabir, A.K.M.H., Ahmed, K.G.U. and Rahman, M.M., 2021b. Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh. PLOS ONE, [online] 16(4), p.e0249252. https://doi.org/10.1371/JOURNAL.PONE.0249252.
Muñiz-Diaz, E., Llopis, J., Parra, R., Roig, I., Ferrer, G., Grifols, J., Millán, A., Ene, G., Ramiro, L., Maglio, L., García, N., Pinacho, A., Jaramillo, A., Peró, A., Artaza, G., Vallés, R., Sauleda, S., Puig, Ll. and Contreras, E., 2021. Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients. Blood Transfusion, [online] 19(1), p.54. https://doi.org/10.2450/2020.0256-20.
N, Z., D, Z., W, W., X, L., B, Y., J, S., X, Z., B, H., W, S., R, L., P, N., F, Z., X, M., D, W., W, X., G, W., GF, G. and W, T., 2020. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine, [online] 382(8), pp.727–733. https://doi.org/10.1056/NEJMOA2001017.
Pourali, F., Afshari, M., Alizadeh-Navaei, R., Javidnia, J., Moosazadeh, M. and Hessami, A., 2020. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis. New Microbes and New Infections, 37, p.100743. https://doi.org/10.1016/j.nmni.2020.100743.
Ray, J.G., Schull, M.J., Vermeulen, M.J. and Park, A.L., 2021. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study. Annals of internal medicine, [online] 174(3), pp.308–315. https://doi.org/10.7326/M20-4511.
Rothan, H.A. and Byrareddy, S.N., 2020. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, https://doi.org/10.1016/j.jaut.2020.102433.
S, K., R, S., MA, S., A, A., J, L., Q, B., N, B. and M, X., 2020. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. Journal of clinical microbiology, [online] 58(5). https://doi.org/10.1128/JCM.00187-20.
Samra, S., Habeb, M. and Nafae, R., 2021. ABO groups can play a role in susceptibility and severity of COVID-19. The Egyptian Journal of Bronchology 2021 15:1, [online] 15(1), pp.1–5. https://doi.org/10.1186/S43168-020-00051-W.
Shi, Y., Yu, X., Zhao, H., Wang, H., Zhao, R. and Sheng, J., 2020. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Critical Care, [online] 24(1). https://doi.org/10.1186/s13054-020-2833-7.
VM, C., D, M., D, N. and C, D., 2018. Hosts and Sources of Endemic Human Coronaviruses. Advances in virus research, [online] 100, pp.163–188. https://doi.org/10.1016/BS.AIVIR.2018.01.001.
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E.C. and Zhang, Y.-Z., 2020. A new coronavirus associated with human respiratory disease in China. Nature 2020 579:7798, [online] 579(7798), pp.265–269. https://doi.org/10.1038/s41586-020-2008-3.
Yanardag Acik Mehmet Bankir, D. and Yanardag Acik, D., 2021. Relationship of SARS-CoV-2 Pandemic with Blood Groups. Research Article Transfus Med Hemother, [online] 48, pp.161–167. https://doi.org/10.1159/000515609.
Yaylacı, S., Dheir, H., İşsever, K., Genc, A.B., Şenocak, D., Kocayigit, H., Guclu, E., Suner, K., Ekerbicer, H. and Koroglu, M., 2020. The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection. Revista da Associação Médica Brasileira, [online] 66(2), pp.86–90. https://doi.org/10.1590/1806-9282.66.S2.86.
Zhang, Y., Garner, R., Salehi, S., la Rocca, M. and Duncan, D., 2021. Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies. Annals of Hematology, https://doi.org/10.1007/s00277-021-04489-w.
Zhao, J., Yang, Y., Huang, H., Li, D., Gu, D., Lu, X., Zhang, Z., Liu, L., Liu, T., Liu, Y., He, Y., Sun, B., Wei, M., Yang, G., Wang, X., Zhang, L., Zhou, X., Xing, M. and Wang, P.G., 2020. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility. Clinical Infectious Diseases. [online] https://doi.org/10.1093/cid/ciaa1150.
Zietz, M., Zucker, J. and Tatonetti, N.P., 2020a. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. https://doi.org/10.1101/2020.04.08.20058073.
Zietz, M., Zucker, J. and Tatonetti, N.P., 2020b. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. https://doi.org/10.1101/2020.04.08.20058073.
Copyright (c) 2022 The Indonesian Journal of Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- The authors agree to transfer the transfer copyright of the article to The Indonesian Journal of Public Health effective if and when the paper is accepted for publication.
- Authors and other parties are bound to the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License for the published articles, legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA), implies that:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.